检索结果 - Daniel Canter

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
    The International Penile Advanced Cancer Trial (InPACT): Rationale and Current Status

    The International Penile Advanced Cancer Trial (InPACT): Rationale and Current Status 由 Daniel Canter, Steve Nicholson, Nick Watkin, Emma Hall, Curtis A. Pettaway

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells

    Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells 由 Konstantin Golovine, Peter Makhov, Ervin Teper, Alexander Kutikov, Daniel Canter, Robert G. Uzzo, Vladimir Kolenko

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Competing Risks of Death in Patients with Localized Renal Cell Carcinoma: A Comorbidity Based Model

    Competing Risks of Death in Patients with Localized Renal Cell Carcinoma: A Comorbidity Based Model 由 Alexander Kutikov, Brian L. Egleston, Daniel Canter, Marc C. Smaldone, Yu‐Ning Wong, Robert G. Uzzo

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Modulation of Akt/mTOR Signaling Overcomes Sunitinib Resistance in Renal and Prostate Cancer Cells

    Modulation of Akt/mTOR Signaling Overcomes Sunitinib Resistance in Renal and Prostate Cancer Cells 由 Peter Makhov, Konstantin Golovine, Alexander Kutikov, Ervin Teper, Daniel Canter, Jay Simhan, Robert G. Uzzo, Vladimir Kolenko

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Co‐administration of piperine and docetaxel results in improved anti‐tumor efficacy via inhibition of CYP3A4 activity

    Co‐administration of piperine and docetaxel results in improved anti‐tumor efficacy via inhibition of CYP3A4 activity 由 Peter Makhov, Konstantin Golovine, Daniel Canter, Alexander Kutikov, Jay Simhan, Melany M. Corlew, Robert G. Uzzo, Vladimir Kolenko

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Prevalence of Baseline Chronic Kidney Disease in Patients Presenting With Solid Renal Tumors

    Prevalence of Baseline Chronic Kidney Disease in Patients Presenting With Solid Renal Tumors 由 Daniel Canter, Alexander Kutikov, Mohit Sirohi, Ryan Street, Rosalia Viterbo, David Y.T. Chen, Richard E. Greenberg, Robert G. Uzzo

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Nephron‐sparing management vs radical nephroureterectomy for low‐ or moderate‐grade, low‐stage upper tract urothelial carcinoma

    Nephron‐sparing management vs radical nephroureterectomy for low‐ or moderate‐grade, low‐stage upper tract urothelial carcinoma 由 Jay Simhan, Marc C. Smaldone, Brian L. Egleston, Daniel Canter, Steven Sterious, Anthony T. Corcoran, Serge Ginzburg, Robert G. Uzzo, Alexander Kutikov

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Objective Measures of Renal Mass Anatomic Complexity Predict Rates of Major Complications Following Partial Nephrectomy

    Objective Measures of Renal Mass Anatomic Complexity Predict Rates of Major Complications Following Partial Nephrectomy 由 Jay Simhan, Marc C. Smaldone, Kevin Tsai, Daniel Canter, Tianyu Li, Alexander Kutikov, Rosalia Viterbo, David Y.T. Chen, Richard E. Greenberg, Robert G. Uzzo

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Small renal masses progressing to metastases under active surveillance

    Small renal masses progressing to metastases under active surveillance 由 Marc C. Smaldone, Alexander Kutikov, Brian L. Egleston, Daniel Canter, Rosalia Viterbo, David Y.T. Chen, Michael A.S. Jewett, Richard E. Greenberg, Robert G. Uzzo

    出版 2011
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  10. 10
    Growth Kinetics and Short-Term Outcomes of cT1b and cT2 Renal Masses under Active Surveillance

    Growth Kinetics and Short-Term Outcomes of cT1b and cT2 Renal Masses under Active Surveillance 由 Reza Mehrazin, Marc C. Smaldone, Alexander Kutikov, Tianyu Li, Jeffrey Tomaszewski, Daniel Canter, Rosalia Viterbo, Richard E. Greenberg, David Y.T. Chen, Robert G. Uzzo

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Assessing Performance Trends in Laparoscopic Nephrectomy and Nephron-sparing Surgery for Localized Renal Tumors

    Assessing Performance Trends in Laparoscopic Nephrectomy and Nephron-sparing Surgery for Localized Renal Tumors 由 Marc C. Smaldone, Alexander Kutikov, Brian L. Egleston, Jay Simhan, Daniel Canter, Ervin Teper, Rosalia Viterbo, David Y.T. Chen, Richard E. Greenberg, Robert G. Uzzo

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma

    Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma 由 Daniel M. Geynisman, Elizabeth A. Handorf, Yu‐Ning Wong, Jamie Doyle, Elizabeth R. Plimack, Eric M. Horwitz, Daniel Canter, Robert G. Uzzo, Alexander Kutikov, Marc C. Smaldone

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Utility of the R.E.N.A.L. Nephrometry Scoring System in Objectifying Treatment Decision-making of the Enhancing Renal Mass

    Utility of the R.E.N.A.L. Nephrometry Scoring System in Objectifying Treatment Decision-making of the Enhancing Renal Mass 由 Daniel Canter, Alexander Kutikov, Brandon J. Manley, Brian L. Egleston, Jay Simhan, Marc C. Smaldone, Ervin Teper, Rosalia Viterbo, David Y.T. Chen, Richard E. Greenberg, Robert G. Uzzo

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Anatomic Features of Enhancing Renal Masses Predict Malignant and High-Grade Pathology: A Preoperative Nomogram Using the RENAL Nephrometry Score

    Anatomic Features of Enhancing Renal Masses Predict Malignant and High-Grade Pathology: A Preoperative Nomogram Using the RENAL Nephrometry Score 由 Alexander Kutikov, Marc C. Smaldone, Brian L. Egleston, Brandon J. Manley, Daniel Canter, Jay Simhan, Stephen A. Boorjian, Rosalia Viterbo, David Y.T. Chen, Richard E. Greenberg, Robert G. Uzzo

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150 Trial

    Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150 Trial 由 Johann S. de Bono, He Meng, Zhen Shi, Małgorzata Nowicka, Sergio Bracarda, Cora N. Sternberg, Kim N., David Olmos, Shahneen Sandhu, Christophe Massard, Nobuaki Matsubara, Geng Chen, Nives Selak Bienz, Daniel Canter, Matthew Wongchenko, Christopher J. Sweeney

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Intravesical rAd–IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin–Refractory or Relapsed Non–Muscle-Invasive Bladder Cancer: A Phase II Randomized Study

    Intravesical rAd–IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin–Refractory or Relapsed Non–Muscle-Invasive Bladder Cancer: A Phase II Randomized Study 由 Neal D. Shore, Stephen A. Boorjian, Daniel Canter, Kenneth Ogan, Lawrence I. Karsh, Tracy M. Downs, Leonard G. Gomella, Ashish M. Kamat, Yair Lotan, Robert S. Svatek, Trinity J. Bivalacqua, Robert L. Grubb, Tracey L. Krupski, Seth P. Lerner, Michael Woods, Brant A. Inman, Matthew I. Milowsky, Alan Boyd, F. Peter Treasure, Gillian Gregory, David G. Sawutz, Seppo Ylä‐Herttuala, Nigel Parker, Colin P. Dinney

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial

    Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial... 由 Vikram M. Narayan, Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety, Neal D. Shore, Leonard G. Gomella, Ashish M. Kamat, Trinity J. Bivalacqua, Jeffrey S. Montgomery, Seth P. Lerner, Joseph E. Busby, Michael Poch, Paul L. Crispen, Gary D. Steinberg, Anne Schuckman, Tracy M. Downs, Joseph Mashni, Brian R. Lane, Thomas J. Guzzo, Gennady Bratslavsky, Lawrence I. Karsh, Michael Woods, Gordon Brown, Daniel Canter, Adam Luchey, Yair Lotan, Brant A. Inman, Michael B. Williams, Michael S. Cookson, Sam S. Chang, Alexander I. Sankin, Michael A. O’Donnell, David G. Sawutz, Richard Philipson, Nigel Parker, Seppo Ylä‐Herttuala, Dorte Rehm, Jørn S. Jakobsen, Kristian Vinter Juul, Colin P. Dinney

    出版 2024
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

    Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial 由 Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety, Neal D. Shore, Leonard G. Gomella, Ashish M. Kamat, Trinity J. Bivalacqua, Jeffrey S. Montgomery, Seth P. Lerner, Joseph E. Busby, Michael Poch, Paul L. Crispen, Gary D. Steinberg, Anne Schuckman, Tracy M. Downs, Robert S. Svatek, Joseph Mashni, Brian R. Lane, Thomas J. Guzzo, Gennady Bratslavsky, Lawrence I. Karsh, Michael Woods, Gordon Brown, Daniel Canter, Adam Luchey, Yair Lotan, Tracey L. Krupski, Brant A. Inman, Michael B. Williams, Michael S. Cookson, Kirk A. Keegan, Gerald L. Andriole, Alexander I. Sankin, Alan Boyd, Michael A. O’Donnell, David G. Sawutz, Richard Philipson, Ruth Coll, Vikram M. Narayan, F. Peter Treasure, Seppo Ylä‐Herttuala, Nigel Parker, Colin P. Dinney

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: